BCLAF1 and hepatocellular carcinoma: BCLAF1 interacts with members of the Bcl2 family of anti-apoptotic proteins and enhances HIF1α expression in HCC tissues under hypoxic conditions, thereby promoting HCC-related angiogenesis and disease progression.